SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-347660
Filing Date
2012-08-09
Accepted
2012-08-09 16:31:53
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d361426d10q.htm 10-Q 471143
2 SECTION 302 CEO CERTIFICATION d361426dex311.htm EX-31.1 10130
3 SECTION 302 CFO CERTIFICATION d361426dex312.htm EX-31.2 10517
4 SECTION 906 CEO AND CFO CERTIFICATION d361426dex321.htm EX-32.1 5228
  Complete submission text file 0001193125-12-347660.txt   4087880

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aria-20120630.xml EX-101.INS 532549
6 XBRL TAXONOMY EXTENSION SCHEMA aria-20120630.xsd EX-101.SCH 42638
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aria-20120630_cal.xml EX-101.CAL 65461
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aria-20120630_def.xml EX-101.DEF 248435
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aria-20120630_lab.xml EX-101.LAB 342779
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aria-20120630_pre.xml EX-101.PRE 295687
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21696 | Film No.: 121020766
SIC: 2836 Biological Products, (No Diagnostic Substances)